Differential Impact of Clinical Factors for Predicting High Platelet Reactivity on Clinical Outcomes in Acute Myocardial Infarction Patients Treated With Clopidogrel and Prasugrel
CONCLUSIONS: Clinical factors listed in the HHD-GENE score may help stratify ischemic risks in patients with acute MI treated with clopidogrel and prasugrel, whereas risk stratification without genetic testing in patients treated with clopidogrel may be challenging.PMID:37316266 | DOI:10.5551/jat.64217
Source: Journal of Atherosclerosis and Thrombosis - Category: Cardiology Authors: Hiroki Goto Yuichi Saito Tadahiro Matsumoto Takanori Sato Daichi Yamashita Sakuramaru Suzuki Shinichi Wakabayashi Hideki Kitahara Koichi Sano Yoshio Kobayashi Source Type: research
More News: Angioplasty | Cardiology | Cardiovascular | Chronic Kidney Disease | Clopidogrel | Coronary Angioplasty | Diabetes | Dialysis | Endocrinology | Genetics | Heart | Heart Attack | Hemodialysis | Hypertension | Ischemic Stroke | Percutaneous Coronary Intervention | Plavix | Stroke | Thrombosis | Urology & Nephrology